Live Webinar on "How to Invest successfully to reach goals without losing sleep" Sign up for Live Webinar

USFDA completes inspections at Alkem Laboratories’ two facilities

26 Aug 2019

US Food and Drug Administration (USFDA) has completed inspections at Alkem Laboratories’ two manufacturing facilities. The agency has conducted inspection at St. Louis, USA from August 16, 2019 to August 22, 2019 and Baddi, India from August 19, 2019 to August 23, 2019.

At the end of the inspection, the company has received a Form 483 with four observations for the facility located at St. Louis and no Form 483 is received for the facility located at Baddi.

Alkem Laboratories is a leading Indian pharmaceutical company with global operations, engaged in the development, manufacture and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical Ingredients (APIs) and nutraceuticals, which it markets in India and International markets.

Related Alkem Laboratories Ltd. Links:

Alkem Laboratories Share Price

3137.20 -30.10 (-0.95%) Jun 18, 18:03
1 Year Price Chart
Peers
Company Name CMP
Sun Pharma Inds. 668.40
Dr. Reddys Lab 5284.60
Lupin 1157.15
Piramal Enterprises 2233.90
Cadila Healthcare 620.20
View more..
Sensex vs Alkem Laboratories
Puchho Befikar
SEBI Registered: Investment Adviser - INA000013323

Callback